HEADER ONCOPROTEIN 12-JUL-20 6XRG TITLE ABL 1B ISOFORM INACTIVE2 STATE COMPND MOL_ID: 1; COMPND 2 MOLECULE: TYROSINE-PROTEIN KINASE ABL1; COMPND 3 CHAIN: A; COMPND 4 SYNONYM: ABELSON MURINE LEUKEMIA VIRAL ONCOGENE HOMOLOG 1,ABELSON COMPND 5 TYROSINE-PROTEIN KINASE 1,PROTO-ONCOGENE C-ABL,P150; COMPND 6 EC: 2.7.10.2; COMPND 7 ENGINEERED: YES; COMPND 8 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: ABL1, ABL, JTK7; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI BL21(DE3); SOURCE 7 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: BL21(DE3) KEYWDS ABL ISOFORM 1B, ONCOPROTEIN EXPDTA SOLUTION NMR NUMMDL 20 AUTHOR T.XIE,T.SALEH,P.ROSSI,C.G.KALODIMOS REVDAT 5 15-MAY-24 6XRG 1 REMARK REVDAT 4 14-JUN-23 6XRG 1 REMARK REVDAT 3 21-OCT-20 6XRG 1 JRNL REVDAT 2 14-OCT-20 6XRG 1 JRNL REVDAT 1 07-OCT-20 6XRG 0 JRNL AUTH T.XIE,T.SALEH,P.ROSSI,C.G.KALODIMOS JRNL TITL CONFORMATIONAL STATES DYNAMICALLY POPULATED BY A KINASE JRNL TITL 2 DETERMINE ITS FUNCTION. JRNL REF SCIENCE V. 370 2020 JRNL REFN ESSN 1095-9203 JRNL PMID 33004676 JRNL DOI 10.1126/SCIENCE.ABC2754 REMARK 2 REMARK 2 RESOLUTION. NOT APPLICABLE. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS, PSVS REMARK 3 AUTHORS : BRUNGER, ADAMS, CLORE, GROS, NILGES AND READ REMARK 3 (CNS), BHATTACHARYA AND MONTELIONE (PSVS) REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 6XRG COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 13-JUL-20. REMARK 100 THE DEPOSITION ID IS D_1000250588. REMARK 210 REMARK 210 EXPERIMENTAL DETAILS REMARK 210 EXPERIMENT TYPE : NMR REMARK 210 TEMPERATURE (KELVIN) : 283 REMARK 210 PH : 7.7 REMARK 210 IONIC STRENGTH : 100 REMARK 210 PRESSURE : 1 ATM REMARK 210 SAMPLE CONTENTS : 250 UM [U-100% 13C; U-100% 15N; REMARK 210 U-100% 2H] ABL 1B G269E/M309L/ REMARK 210 T408Y VARIANT, 25 MM SODIUM REMARK 210 PHOSPHATE, 75 MM SODIUM CHLORIDE, REMARK 210 2.5 MM BETA-MERCAPTOETHANOL, 90% REMARK 210 H2O/10% D2O; 250 UM N-ILVMAT-FY REMARK 210 ABL 1B G269E/M309L/T408Y VARIANT, REMARK 210 25 MM SODIUM PHOSPHATE, 75 MM REMARK 210 SODIUM CHLORIDE, 2.5 MM BETA- REMARK 210 MERCAPTOETHANOL, 90% H2O/10% D2O REMARK 210 REMARK 210 NMR EXPERIMENTS CONDUCTED : 2D 1H-13C HSQC AROMATIC; 2D 1H REMARK 210 -13C HMQC; 2D 1H-15N TROSY; 3D REMARK 210 1H-15N NOESY; 3D 1H-13C NOESY REMARK 210 ALIPHATIC; 3D 1H-13C NOESY REMARK 210 AROMATIC; 3D CCH NOESY; 3D REMARK 210 CACMHM_SOFASTNOESY REMARK 210 SPECTROMETER FIELD STRENGTH : 1100 MHZ; 850 MHZ REMARK 210 SPECTROMETER MODEL : AVANCE REMARK 210 SPECTROMETER MANUFACTURER : BRUKER REMARK 210 REMARK 210 STRUCTURE DETERMINATION. REMARK 210 SOFTWARE USED : CYANA, I-PINE, SPARKY, TALOS, REMARK 210 TOPSPIN, NMRPIPE REMARK 210 METHOD USED : MOLECULAR DYNAMICS REMARK 210 REMARK 210 CONFORMERS, NUMBER CALCULATED : 100 REMARK 210 CONFORMERS, NUMBER SUBMITTED : 20 REMARK 210 CONFORMERS, SELECTION CRITERIA : TARGET FUNCTION REMARK 210 REMARK 210 BEST REPRESENTATIVE CONFORMER IN THIS ENSEMBLE : 1 REMARK 210 REMARK 210 REMARK: NULL REMARK 215 REMARK 215 NMR STUDY REMARK 215 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM SOLUTION REMARK 215 NMR DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE THAT REMARK 215 CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES ON REMARK 215 THESE RECORDS ARE MEANINGLESS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 5 PRO A 329 C - N - CA ANGL. DEV. = 9.4 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 1 VAL A 279 -151.75 173.84 REMARK 500 1 TRP A 280 -164.84 -123.72 REMARK 500 1 LYS A 282 -169.19 -161.43 REMARK 500 1 VAL A 299 74.55 -68.62 REMARK 500 1 GLU A 301 -15.90 -47.52 REMARK 500 1 GLU A 327 150.01 76.58 REMARK 500 1 PRO A 328 147.17 -22.44 REMARK 500 1 PRO A 329 157.37 -11.09 REMARK 500 1 CYS A 349 35.08 -80.32 REMARK 500 1 ARG A 381 -35.19 76.80 REMARK 500 1 MET A 407 47.60 -151.70 REMARK 500 1 HIS A 415 99.02 -55.76 REMARK 500 1 ALA A 416 39.09 -85.64 REMARK 500 1 ASP A 474 20.78 146.83 REMARK 500 1 SER A 520 -156.08 -140.01 REMARK 500 1 ILE A 521 120.34 -38.24 REMARK 500 1 ASP A 523 -68.37 68.29 REMARK 500 1 GLU A 524 -141.73 -75.10 REMARK 500 2 ASP A 252 -159.97 -152.13 REMARK 500 2 VAL A 279 -154.82 177.35 REMARK 500 2 TRP A 280 -161.67 -123.47 REMARK 500 2 VAL A 299 82.05 -66.87 REMARK 500 2 GLU A 327 150.90 75.47 REMARK 500 2 PRO A 328 145.62 -22.45 REMARK 500 2 PRO A 329 163.32 -4.40 REMARK 500 2 CYS A 349 40.32 -84.29 REMARK 500 2 ARG A 381 -33.10 75.20 REMARK 500 2 ALA A 414 -155.99 -139.56 REMARK 500 2 HIS A 415 -84.04 70.06 REMARK 500 2 ALA A 416 -78.19 59.59 REMARK 500 2 ALA A 418 10.86 -154.49 REMARK 500 2 LYS A 419 77.45 56.01 REMARK 500 2 ASP A 474 31.97 138.54 REMARK 500 2 GLN A 532 99.19 -68.62 REMARK 500 3 ASP A 252 -159.24 -150.37 REMARK 500 3 VAL A 279 -152.06 176.20 REMARK 500 3 TRP A 280 -162.31 -127.77 REMARK 500 3 LYS A 282 -167.26 -168.67 REMARK 500 3 ASP A 295 32.57 -96.07 REMARK 500 3 VAL A 299 78.33 -66.47 REMARK 500 3 GLU A 301 -18.84 -49.84 REMARK 500 3 GLU A 327 149.62 76.03 REMARK 500 3 PRO A 328 144.44 -22.57 REMARK 500 3 PRO A 329 157.48 -16.91 REMARK 500 3 CYS A 349 48.34 -87.81 REMARK 500 3 ARG A 381 -31.13 75.44 REMARK 500 3 TYR A 408 -110.87 -98.34 REMARK 500 3 HIS A 415 81.77 -69.73 REMARK 500 3 PRO A 421 79.92 -66.32 REMARK 500 3 ASP A 474 26.62 137.30 REMARK 500 REMARK 500 THIS ENTRY HAS 360 RAMACHANDRAN OUTLIERS. REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 THR A 411 TYR A 412 1 131.36 REMARK 500 THR A 411 TYR A 412 2 127.04 REMARK 500 PRO A 328 PRO A 329 4 -148.03 REMARK 500 THR A 411 TYR A 412 4 132.61 REMARK 500 GLY A 402 LEU A 403 5 -146.29 REMARK 500 ASP A 410 THR A 411 5 145.66 REMARK 500 THR A 411 TYR A 412 5 141.04 REMARK 500 ASP A 410 THR A 411 7 149.73 REMARK 500 THR A 411 TYR A 412 7 133.45 REMARK 500 ASP A 410 THR A 411 9 140.66 REMARK 500 THR A 411 TYR A 412 9 133.62 REMARK 500 THR A 411 TYR A 412 11 -149.46 REMARK 500 ASP A 410 THR A 411 12 139.35 REMARK 500 THR A 411 TYR A 412 12 134.30 REMARK 500 PRO A 328 PRO A 329 13 -146.42 REMARK 500 ASP A 410 THR A 411 15 146.27 REMARK 500 THR A 411 TYR A 412 15 133.74 REMARK 500 PRO A 328 PRO A 329 16 -148.65 REMARK 500 ASP A 410 THR A 411 16 149.39 REMARK 500 THR A 411 TYR A 412 16 133.74 REMARK 500 ASP A 410 THR A 411 19 149.34 REMARK 500 THR A 411 TYR A 412 19 126.68 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 30772 RELATED DB: BMRB REMARK 900 DISTINCT CONFORMATIONAL STATES DYNAMICALLY POPULATED BY ABL KINASE REMARK 900 DETERMINE ITS RESPONSE TO PHYSIOLOGICAL AND PATHOLOGICAL PROCESSES DBREF 6XRG A 248 534 UNP P00519 ABL1_HUMAN 229 515 SEQADV 6XRG GLU A 269 UNP P00519 GLY 250 ENGINEERED MUTATION SEQADV 6XRG LEU A 309 UNP P00519 MET 290 ENGINEERED MUTATION SEQADV 6XRG TYR A 408 UNP P00519 THR 389 ENGINEERED MUTATION SEQRES 1 A 287 SER PRO ASN TYR ASP LYS TRP GLU MET GLU ARG THR ASP SEQRES 2 A 287 ILE THR MET LYS HIS LYS LEU GLY GLU GLY GLN TYR GLY SEQRES 3 A 287 GLU VAL TYR GLU GLY VAL TRP LYS LYS TYR SER LEU THR SEQRES 4 A 287 VAL ALA VAL LYS THR LEU LYS GLU ASP THR MET GLU VAL SEQRES 5 A 287 GLU GLU PHE LEU LYS GLU ALA ALA VAL LEU LYS GLU ILE SEQRES 6 A 287 LYS HIS PRO ASN LEU VAL GLN LEU LEU GLY VAL CYS THR SEQRES 7 A 287 ARG GLU PRO PRO PHE TYR ILE ILE THR GLU PHE MET THR SEQRES 8 A 287 TYR GLY ASN LEU LEU ASP TYR LEU ARG GLU CYS ASN ARG SEQRES 9 A 287 GLN GLU VAL ASN ALA VAL VAL LEU LEU TYR MET ALA THR SEQRES 10 A 287 GLN ILE SER SER ALA MET GLU TYR LEU GLU LYS LYS ASN SEQRES 11 A 287 PHE ILE HIS ARG ASP LEU ALA ALA ARG ASN CYS LEU VAL SEQRES 12 A 287 GLY GLU ASN HIS LEU VAL LYS VAL ALA ASP PHE GLY LEU SEQRES 13 A 287 SER ARG LEU MET TYR GLY ASP THR TYR THR ALA HIS ALA SEQRES 14 A 287 GLY ALA LYS PHE PRO ILE LYS TRP THR ALA PRO GLU SER SEQRES 15 A 287 LEU ALA TYR ASN LYS PHE SER ILE LYS SER ASP VAL TRP SEQRES 16 A 287 ALA PHE GLY VAL LEU LEU TRP GLU ILE ALA THR TYR GLY SEQRES 17 A 287 MET SER PRO TYR PRO GLY ILE ASP LEU SER GLN VAL TYR SEQRES 18 A 287 GLU LEU LEU GLU LYS ASP TYR ARG MET GLU ARG PRO GLU SEQRES 19 A 287 GLY CYS PRO GLU LYS VAL TYR GLU LEU MET ARG ALA CYS SEQRES 20 A 287 TRP GLN TRP ASN PRO SER ASP ARG PRO SER PHE ALA GLU SEQRES 21 A 287 ILE HIS GLN ALA PHE GLU THR MET PHE GLN GLU SER SER SEQRES 22 A 287 ILE SER ASP GLU VAL GLU LYS GLU LEU GLY LYS GLN GLY SEQRES 23 A 287 VAL HELIX 1 AA1 GLU A 257 ILE A 261 5 5 HELIX 2 AA2 GLU A 301 ILE A 312 1 12 HELIX 3 AA3 ASN A 341 CYS A 349 1 9 HELIX 4 AA4 ASN A 355 LYS A 376 1 22 HELIX 5 AA5 PRO A 421 THR A 425 5 5 HELIX 6 AA6 ALA A 426 TYR A 432 1 7 HELIX 7 AA7 SER A 436 THR A 453 1 18 HELIX 8 AA8 ASP A 463 ASP A 474 1 12 HELIX 9 AA9 PRO A 484 TRP A 495 1 12 HELIX 10 AB1 SER A 504 GLN A 517 1 14 SHEET 1 AA1 5 THR A 262 GLY A 268 0 SHEET 2 AA1 5 VAL A 275 VAL A 279 -1 O VAL A 275 N GLY A 268 SHEET 3 AA1 5 VAL A 287 THR A 291 -1 O VAL A 289 N TYR A 276 SHEET 4 AA1 5 TYR A 331 GLU A 335 -1 O THR A 334 N ALA A 288 SHEET 5 AA1 5 LEU A 320 CYS A 324 -1 N CYS A 324 O TYR A 331 SHEET 1 AA2 2 CYS A 388 VAL A 390 0 SHEET 2 AA2 2 VAL A 396 VAL A 398 -1 O LYS A 397 N LEU A 389 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000 MODEL 1